GVA vs ACA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

GVA

39.4
AI Score
VS
ACA Wins

ACA

61.5
AI Score

Investment Advisor Scores

GVA

39score
Recommendation
AVOID NEW MONEY

ACA

62score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GVA ACA Winner
Forward P/E 13.8504 29.8507 GVA
PEG Ratio 0.1108 1.8642 GVA
Revenue Growth 29.3% 1.7% GVA
Earnings Growth 25.1% 448.6% ACA
Tradestie Score 39.4/100 61.5/100 ACA
Profit Margin -3.3% 16.8% ACA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD ACA

Relative Price Performance (Last 90 Days)

GVA 1M: -4.6% · 3M: -13.7% ACA 1M: +1.8% · 3M: +2.9%

Current Technical Phase

GVA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.3%), weak momentum, RSI 37

RSI (14): 36.6 · Price: $107.45

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 82

RSI (14): 82.2 · Price: $149.15

Fundamentals Snapshot

Metric GVA ACA
Market Cap — —
Forward P/E 13.5 29.1
Trailing P/E — 36.4
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS -4.32 4.09
Dividend Yield 0.00% 0.00%

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.